FENC
Fennec Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.27
+2.91%Forward multiples
Based on analyst estimates
- P/E forward
- 14.02x
- P/E 2026E
- 36.05x
- P/E 2027E
- 10.85x
- P/E 2028E
- 6.23x
- P/S forward
- 3.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.49x
- Price / sales
- 6.08x
- Price / cash flow
- -176.54x
Enterprise value
- Enterprise value
- $318.9M
- EV / sales
- 5.38x
- EV / EBITDA
- -134.16x
- EV / EBIT
- -274.20x
- Market cap
- $360.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026